Colgate Palmolive Stock Jumps On FY Q1 Results

Colgate-Palmolive India was up 0.57% to Rs 380.25 on registering 68.82% growth in net profit in Q1 June 2007. The results were announced in the market hours today, 27 July 2007.

Case Against Haneef About To Unravel - Lawyer

Dr. Mohammed HaneefMelbourne: According to a top independent legal expert that the resolution of Australia’s Director of Public Prosecutions to assess the case against the apprehended Indian doctor Mohammed Haneef advised that the lawsuit was about to disintegrate

While commenting on the decision of Damian Bugg, the ex-chairman of the National Crime Authority, Peter Faris stated, “This is the end of the case against Haneef.”

Hold Thermax: P-Sec

Broking houseThermax Ltd., P-Sec recommended hold rating on Thermax.

P-Sec report on Thermax:

Thermax reported a growth of 107% yoy and a bottom line growth of 103% yoy. The results bettered our expectations with a big margin, the EBITDA margins sank by 38 bps yoy. The management had given a rich guidance of 40% yoy growth for FY08 and have maintained there position of stable to better margins.

The current order book stands at Rs. 36.72bln (0up by 66%yoy) that is 1.42x net sales of FY07 offering visibility for future growth.

Investors Should Know The Real Meaning Of Volatility - Experts

It was a jerky session on Dalal Street. After a hopeful beginning, the indices came below a session of profit booking and trimmed off the majority of the day’s gains. The Nifty ended flat at 4,620 points after gaining just 1.40 points, whereas the Sensex ended the day at 15,795, up 63 points.

The stock markets closed on a flat note after a quite impulsive session. The boarder markets ended in the red with a weak breadth. In the F&O section, the return was the highest ever at Rs 64,281 crore.

IT, capital goods and IT stocks - Reliance Energy, Satyam, BHEL, NTPC, and HDFC Bank ended the day in the green, ended higher. But, selling pressure was seen in auto, FMCG, and pharma stocks.

IFCI Tops Volume On BSE

Industrial Finance Corporation of IndiaIn early trades, Industrial Finance

Sharekhan Research Maintained Buy for Sun Pharma, Target Rs 1287

Sun Pharmaceutical IndustriesSharekhan Research maintained purchase rating on Sun Pharmaceutical Industries with target price of Rs 1287. At current market price Rs 965, stock valued at 21.6x FY2008E and 18.1xFY2009E fully diluted earnings.

Result highlights:

Pages

News in Focus

Players Use MocPOGO to Spoof Pokémon GO Location Without Getting Banned

As Pokemon GO becomes ever more popular, players around the globe are seeking safer, smarter ways to explore rare Pokemon spawns and participate in global raids--without leaving home.

Sun Pharmaceutical Share Price Target at Rs 1,960: Motilal Oswal Research

Motilal Oswal Financial Services has reiterated its BUY recommendation for Sun Pharma, assigning a 12-month target price of Rs 1,960, with the stock currently trading at Rs 1,690.

Ambuja Cements Share Price Target at Rs 718: Prabhudas Lilladher

Prabhudas Lilladher has reiterated BUY Call for Ambuja Cements, anchoring its target price at a solid Rs 718 per share.

Bharti Airtel Share Price Target at Rs 2,259: Prabhudas Lilladher

Prabhudas Lilladher research has issued an Accumulate Call on telecom major Bharti Airtel, driven by an impressive Q2FY26 performance that surpassed expectations.

From Cash to Crypto: How Indians Are Banking Differently in the Digital Age

There’s a quiet revolution happening in India’s financial world, and it’s not just about new banking apps or UPI limits being raised. It’s about how people think about money altogether.

Mahindra & Mahindra Share Price Target at Rs 4,122: Motilal Oswal Research

Motilal Oswal, a leading research house, has reiterated a BUY call on Mahindra & Mahindra (M&M) with a target price of Rs 4,122, citing robust earnings, margin expansion, and strong growth